Fallouh Healthcare wins funding to develop device providing early diagnosis of cardiac tamponade
Birmingham-based Fallouh Healthcare has been awarded a grant of £305,050 from Innovate UK as part of the Eureka Eurostar programme to finalise a prototype of PerDeCT™, working alongside their Austrian partner the Medizinische Universität Wien, which aims to be the first device for monitoring cardiac function and early diagnosis of cardiac tamponade, a life-threatening complication after heart surgery.
Although cardiac surgery is safe, cardiac tamponade can come on quickly – usually after the patient has left theatre, and typically late at night when the patient is in intensive care.
It is caused by the accumulation ...